Full-Time

Senior Regional Field Educator

Cas

Posted on 12/13/2025

Deadline 12/22/25
Medtronic

Medtronic

10,001+ employees

Medical device maker advancing therapies

Compensation Overview

$130k - $150k/yr

+ Sales Incentive Plan (SIP)

California, USA

Hybrid

Must reside in California; travel to accounts regionally up to 50-75% of the time.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor’s degree PLUS a minimum of 4 years of experience in electrophysiology or sales/service/engineering in the Cardiac Ablation, Cardiac Rhythm, or Implantable Medical Device Industry
  • OR Advanced Degree in Engineering or Nursing and 2 years of experience in electrophysiology or sales/service/engineering in the Cardiac Ablation, Cardiac Rhythm, or Implantable Medical Device Industry
Responsibilities
  • Implement and execute the strategy and implementation plan for educational programs for new and tenured sales representatives and clinical specialists to drive electrophysiology product procedures across the CAS portfolio of cardiac ablation products.
  • Play an integral role in executing the training and education strategy for the US sales team as the business enters multiple new market segments and expands the cardiac ablation portfolio with advanced technologies.
  • Serve as the lead for regional customer and employee education and training activities in support of CAS procedure and product launches.
  • Partner with key leadership, sales field and cross functional personnel to identify opportunities for and barriers to improving regional performance.
  • Serve as the customer and field technical resource in CAS, providing expertise and leadership in Physician and Field education, AHP education, clinical evidence interpretation, and Medtronic employee education.
  • Provide feedback to product development, internal training and education on content development and the marketing team to improve future offerings.
  • Drives regional education and training activities.
  • Train and educate internal teams and external customers on CAS procedures, therapies/products, processes, and solutions.
  • Continued education and assessment of tenured field team.
  • Leads coordination of new-hire training with accountability to hiring manager (CSM or RM).
  • Responsible for new hire sign-off.
  • Delivers new product and procedural field training and ensures that all required technical and clinical evidence for our products is delivered in a manner that our field teams can articulate to customers.
  • Execute engaging field sales and clinical specialist field education programs that are targeted, purposeful, and support electrophysiology knowledge and skills in procedures and cardiac ablation therapies based on needs of the US Sales organization objectives.
  • Understands competitive technology and therapies and can craft a message as to why Medtronic therapies provide a competitive advantage.
  • Disseminate competitive information to regional teams
  • Delivers competitive technical and clinical training to sales teams in collaboration with sales leaders/marketing
  • Enhances relationships with current and future stakeholders by delivering strategic and innovative education to promote Medtronic products and therapies while focusing on clinical value
  • Collaborates to roll out new product training initiatives; new products’ indications, troubleshooting/tips and tricks, safety updates - “Train the Trainer”
  • Translates complex technical messaging, dispels competitive claims, resolves complex technical issues, and maintains customer relationships through technical expertise
  • Understands, interprets, and participates in communication of product and procedure updates and field corrective actions pertinent to Medtronic products and therapies
  • Collaborates with clinical research organization relative to clinical studies and physician research
  • Commitment to personal continued development in electrophysiology field and adult learning modalities
  • Partners with sales leadership intentionally and effectively to develop and execute strategic technical and clinical training that meet business goals
  • Leverages personal region wide relationships and experience to anticipate changes in business conditions
  • Responds to urgent or rapidly changing business needs and partners with sales teams to implement strategic solutions
  • Builds and strengthens relationships across Medtronic to support collaborative solutions that leverage our unique sales and clinical teams
  • Builds and maintains high trust relationships based on technical expertise and clinical evidence with key customers across the region
  • Provides expert service at key accounts to establish and reinforce the value of Medtronic technical competency
Desired Qualifications
  • The successful candidate will preferably have experience in marketing new technologies and therapies
  • Degree in biomedical engineering or nursing
  • Cath Lab, EP Lab, hospital/clinic, or cardiology experience
  • Experience teaching and educating medical personnel, peers, and technical support personnel
  • Thorough working knowledge of cardiac medical terminology and the medical device industry
  • Excellent customer service skills
  • Proven ability to build/maintain positive relationships with peers and colleagues across organization levels
  • Excellent interpersonal, written/verbal communication skills
  • Ability to coordinate/participate in numerous tasks/projects in a fast paced environment in an organized manner while meeting deadlines
  • Strong work ethic in accomplishing objectives of the position
  • Expertise with Microsoft tools and other business applications (i.eSalesForce)
  • Ability to meet vendor credentialing requirements
  • IBHRE/RCES certification (preferred at Sr and Prin levels)
  • Practical and demonstrated knowledge of project/program management practices desired for Senior and Principal Levels with the ability to complete work group objectives with little guidance

Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Designation accelerates Sphere-9 VT pivotal trial.
  • Led $100M Pulnovo Medical round for heart failure therapy.
  • $20M Orchestra BioMed investment advances hypertension trial.

What critics are saying

  • ShinyHunters exfiltrates 9M records, triggers lawsuits by Q3 2026.
  • Jefferies cuts price target to $95, stock drops 10% in weeks.
  • MiniMed IPO spins out diabetes unit, dilutes revenue by 2027.

What makes Medtronic unique

  • Pioneered first wearable battery-powered pacemaker in 1957.
  • Developed Affera Sphere-9 catheter with dual-energy ablation for VT.
  • Launched Stealth AXiS AI-powered surgical navigation system.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Yahoo Finance
Apr 10th, 2026
GE HealthCare and Medtronic launch integrated neurosurgery imaging and navigation system

Medtronic and GE HealthCare have launched a digital integration combining GE's bkActiv intraoperative ultrasound with Medtronic's Stealth AXiS surgical navigation system for cranial neurosurgery. The commercially available system provides real-time imaging during procedures, connecting Medtronic's navigation and robotics platforms with GE HealthCare's imaging technology. The integration aims to enhance clinical decision-making during complex cranial procedures through precise guidance and visualisation. It may influence hospital equipment purchasing decisions, surgeon productivity and operating room efficiency. Medtronic currently trades at $87.91, approximately 19.8% below the $109.64 analyst target range midpoint. The stock has experienced a 2.2% decline over the past 30 days. Adoption rates amongst surgeons and hospitals, alongside hospital capital spending on neurosurgery suites, will be key factors to monitor.

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Yahoo Finance
Apr 7th, 2026
Stifel cuts Medtronic price target to $95 from $105 on MiniMed IPO dilution

Stifel has lowered its price target on Medtronic (NYSE:MDT) to $95 from $105, maintaining a Hold rating. The adjustment reflects transaction-related impacts from the 9 March IPO of Medtronic's Diabetes business, now called MiniMed. MiniMed will remain a consolidated subsidiary until formal separation, expected about six months post-IPO. Stifel continues to model full Diabetes business revenue whilst adjusting for the 10% non-controlling interest sold in the IPO. Management expects IPO-related earnings per share dilution of 1-2 cents monthly until separation completes. Separately, the US Food and Drug Administration recently cleared Medtronic's Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding beyond its earlier spine indication.

Silicon Republic
Apr 3rd, 2026
What impact might Medtronic's new lab have on Galway's medtech ecosystem?

What impact might Medtronic's new lab have on Galway's medtech ecosystem? 3 Apr 2026 From left: Ruth Callanan, Ronan Rogers and John Caulfield. Image: Andrew Downes/Xposure Ronan Rogers and Ruth Callanan discuss innovation in the west of Ireland and the evolution of Ireland's STEM careers. Ireland's medtech sector is moving beyond traditional biomedical engineering, according to Ronan Rogers, the senior R&D director for cardiac ablation solutions at Medtronic. He explained the region has built "real depth", not just in medtech, but across key areas such as pharmaceutical science, advanced analytics and digital technology. Areas that are now "increasingly converging". "That diversity of opportunity is a huge strength for Ireland," he told SiliconRepublic.com. "It allows people from different professional backgrounds to find meaningful, high-impact careers in healthcare, while helping Ireland move further up the value chain as a centre for complex, globally relevant innovation." Having recently expanded its Galway-based pharmaceutical laboratory, the Medtronic facility now serves as a west of Ireland hub for high-tech innovation and the evolving needs of the global healthcare space. Rogers is of the opinion that this is reflective of the convergence of the country's medtech divisions. Noting that the primary purpose of the lab "is to integrate pharmaceutical, engineering and analytical expertise under one roof to address the complex challenges of combination products, [that is] where a medical device and a medicine work together". "We see that convergence very clearly in this laboratory and there is a wide range of career paths in our industry, whether that's a pharmacist drawn to the faster innovation cycles and applied science of medtech, or a software developer who wants to use their skills to solve real healthcare challenges and code with a deeper sense of purpose." What opportunities exist? With the expansion comes the opportunity for students and professionals to consider a new role, either as part of Medtronic or within Galway's thriving life science and medtech spaces. "Galway offers a unique innovation ecosystem where infrastructure, academic partnerships and a significant medtech footprint all provide a strong foundation for sustaining Ireland's leadership in the life sciences sector," said Ruth Callanan, Medtronic's director of site quality. With the investment focused on significantly expanding R&D capability and technical depth within a critical space in the Irish medtech sector, Medtronic has increased lab space by almost a half and introduced analytical technologies that didn't exist there before. Callanan said: "This creates the conditions for future high-value work as programmes grow. It strengthens Galway's ability to attract and retain highly specialised talent, pharmaceutical scientists, chemical and materials engineers and it allows work that was previously outsourced internationally to be done here in Ireland. "Over time, as demand and activity scale, we do expect this capability to support additional specialist roles, phased in over the coming years. Importantly, it reinforces Ireland's position at the forefront of advanced medtech R&D and reflects a broader industry trend toward self-sufficiency in high-tech analytical testing." Step into the future. She explained the new lab will enable experts to integrate processes as the facility will be responsible for the entire life cycle of product development, from early phase R&D through to post-market oversight. She added: "The laboratory utilises advanced LCMS [liquid chromatography-mass spectrometry] and GCMS [gas chromatography-mass spectrometry] technologies, which act as 'molecular microscopes'. This allows our scientists to identify unknown compounds or impurities at extremely precise levels." According to Rogers, the new lab has a role to play in what he believes to be the reshaping of how STEM careers in Ireland are perceived and pursued, with Callanan noting this creates for students and professionals opportunities to engage with careers that bridge the gap between various scientific disciplines. "A laboratory of this size and complexity requires students and professionals with a wide range of skills and experience across multiple disciplines," she said. "Just as importantly," added Rogers, "we're sending a clear signal to pharmacists, chemists and analytical scientists that medtech offers deep, intellectually challenging career paths that go well beyond traditional manufacturing or even classical biomedical engineering." Laura Varley is the Careers editor for Silicon Republic

The Irish Post
Mar 31st, 2026
Medtronic launches new pharmaceutical lab in Galway.

Medtronic launches new pharmaceutical lab in Galway. A GLOBAL health tech leader which is headquartered in Galway has unveiled a new laboratory in the city. Medtronic has formally opened a new Pharma Laboratory and Building 6 at its location in Parkmore. Galway TD and Minister of State Seán Canney attended the launch event this month. Minister Seán Canney (centre) attended the opening of the new laboratory this month "Great to be in Parkmore to officially open the new Pharma Laboratory and Building 6 at Medtronic," he said. "This is a really significant investment for Galway and for the West - strengthening our position as a global leader in MedTech and supporting the next generation of innovation." He added: "The facility will act as a "one-stop shop" for testing and validating drug-device combination products - a fast-growing area that is improving outcomes for patients worldwide. "Medtronic has been part of Galway for over 40 years, and what's been built here is genuinely world-class. "It reflects the strength of the talent, the ecosystem, and the ambition that exists across this region. Most importantly, this is about impact - better treatments, better technologies, and better outcomes for patients. "A real vote of confidence in Galway and in Ireland." Everything from irishpost.com and the print edition is available on the Irish Post App - plus more! Download it for Android or Apple IOS devices today.

INACTIVE